Intech Investment Management LLC Purchases Shares of 21,099 Astera Labs, Inc. $ALAB

Intech Investment Management LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 21,099 shares of the company’s stock, valued at approximately $1,908,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company’s stock valued at $554,780,000 after buying an additional 85,846 shares in the last quarter. Alliancebernstein L.P. boosted its stake in Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after buying an additional 4,478,741 shares in the last quarter. Atreides Management LP grew its position in Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after acquiring an additional 2,815,614 shares during the last quarter. Fred Alger Management LLC raised its stake in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after acquiring an additional 179,638 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Astera Labs by 36.2% in the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after acquiring an additional 330,841 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. This trade represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 619,436 shares of company stock worth $96,530,060. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 1.8%

ALAB stock opened at $141.80 on Friday. The firm’s 50-day moving average price is $185.11 and its two-hundred day moving average price is $145.75. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock has a market capitalization of $23.95 billion, a price-to-earnings ratio of 127.75, a PEG ratio of 2.60 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Morgan Stanley upped their price target on shares of Astera Labs from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. BNP Paribas began coverage on Astera Labs in a research note on Thursday. They set an “outperform” rating on the stock. TD Cowen decreased their price objective on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a report on Wednesday, November 5th. Finally, Cowen reissued a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $187.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.